ACD856

ACD856
Clinical data
Other namesACD-856
Routes of
administration		Oral
Drug classTropomyosin receptor kinase TrkA, TrkB, and TrkC positive allosteric modulator
Pharmacokinetic data
Elimination half-life~19 hours

ACD856, or ACD-856, is a tropomyosin receptor kinase TrkA, TrkB, and TrkC positive allosteric modulator which is under development for the treatment of Alzheimer's disease, depressive disorders, sleep disorders, and traumatic brain injuries. It is taken by mouth.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.